JMP Securities downgraded shares of Vascular Biogenics Ltd (NASDAQ:VBLT) from an outperform rating to a market perform rating in a research note released on Tuesday morning, TheFlyOnTheWall.com reports. On Tuesday shares of Vascular Biogenics Ltd. (NASDAQ:VBLT) closed at $4.12. Mylan Inc.’s Indian subsidiary will be the exclusive distributor of Gilead Sciences Inc. (NASDAQ:GILD)’s hepatitis C treatments in that country, in the latest move in the pharmaceutical wars over the market for the liver disease. On Tuesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $104.70. Company’s sales growth for last 5 years was 28.80% and EPS growth for next 5 years is recorded as 25.20%.
Apple Inc (NASDAQ:AAPL) has been ordered to pay $532.9 million (R6.101 billion) after a federal jury found its iTunes software infringed three patents owned by Texas-based patent licensing company Smartflash LLC. Apple Inc. (NASDAQ:AAPL) in last trading activity fell -0.62% to close at $132.17. Company weekly performance is 3.40% while its quarterly performance stands at 14.09%. Apple Inc. (NASDAQ:AAPL) is -0.62% away from its 52 week high.
Merck & Co Inc. (NYSE:MRK) has taken an equity stake in Californian biotech NGM Biopharmaceuticals as part of a five-year alliance focusing on drugs to treat metabolic disorders and cancer. On last trading day Merck & Co. Inc. (NYSE:MRK) moved up 0.10% to close at $58.36. Its volatility for the week is 1.29% while volatility for the month is 1.58%. MRK’s sales growth for past 5 years was 9.00% and its EPS growth for past 5 years was -6.30%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -6.61%.
Athersys, Inc. (NASDAQ:ATHX) will release its 2014 fourth quarter and annual financial results at approximately 4:00 PM EDT on Thursday, March 12, 2015, and host a conference call shortly thereafter at 4:30 PM EDT to review the results. On last trading day Athersys, Inc. (NASDAQ:ATHX) advanced 4.02% to close at $2.59. Its volatility for the week is 6.14% while volatility for the month is 6.84%. ATHX’s sales growth for past 5 years was -5.00% and its EPS growth for past 5 years was 11.00%. Athersys, Inc. (NASDAQ:ATHX) monthly performance is 26.96%.